
Muprich
June 8, 2026
MAPPI-DSR
June 8, 2026MAPPI-LS
Composition : Enteric Coated Rabeprazole Sodium and Levosulpiride SR Capsules
Packaging : 10 x 10
Arion Healthcare designed MAPPI-LS to provide superior, sustained relief from severe gastrointestinal discomfort. By combining a powerful proton pump inhibitor (PPI) with a prokinetic agent, this dual-action formula targets the root causes of acid reflux, heartburn, and poor gastric motility to restore digestive balance and comfort.
Arion Healthcare formulated MAPPI-LS for individuals struggling with chronic gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and severe dyspepsia that does not respond to standard antacids alone.
The formulation utilizes a specialized dual-action delivery system to maximize relief:
-
Enteric-Coated Rabeprazole Sodium: This coating protects the medication so it bypasses the stomach’s harsh acid environment and dissolves directly in the intestine. It rapidly suppresses gastric acid production at the source, stops heartburn, and allows the esophageal lining to heal.
-
Sustained-Release Levosulpiride (SR): This mechanism gradually releases the active ingredient to enhance upper gastrointestinal motility. By increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, it prevents food and acid from backing up into the food pipe.
Key Benefits
-
Fast-Acting Acid Suppression: Shuts down excess acid production rapidly to stop heartburn instantly.
-
Improved Gastric Motility: Promotes faster stomach emptying to eliminate bloating and heaviness.
-
Dual-Action Formula: Treats both chemical (acid) and mechanical (motility) digestive issues simultaneously.
-
Long-Lasting Comfort: Uses sustained-release technology to ensure 24-hour protection against acid reflux.
Indications
Physicians clinically prescribe MAPPI-LS Capsules to manage and treat:
-
Gastroesophageal Reflux Disease (GERD) resistant to PPI monotherapy.
-
Non-Ulcer Dyspepsia (chronic indigestion).
-
Irritable Bowel Syndrome (IBS) associated with delayed gastric emptying.
-
Peptic and Duodenal Ulcers.
-
Hypersecretory conditions like Zollinger-Ellison Syndrome.
Side Effects
While patients generally tolerate MAPPI-LS well under medical supervision, some individuals may experience mild side effects:
-
Headache or dizziness
-
Nausea, diarrhea, or abdominal pain
-
Dry mouth
-
Drowsiness or fatigue
-
Changes in sleep patterns or menstrual irregularities (rare, due to levosulpiride)
Frequently Asked Questions
Q1: What is MAPPI-LS capsule used for?
This capsule treats severe acid reflux, GERD, chronic indigestion, and bloating by reducing stomach acid and improving gut motility.
Q2: When should I take MAPPI-LS capsules?
For maximum efficacy, you should take this capsule in the morning on an empty stomach, at least 30 minutes before breakfast.
Q3: Can women take this medication during pregnancy?
Doctors generally do not recommend MAPPI-LS for pregnant or breastfeeding women unless the clinical safety benefits outweigh the risks.
Q4: Is it safe to drive after taking MAPPI-LS?
This medicine can occasionally cause dizziness or drowsiness; if you experience these symptoms, avoid driving or operating heavy machinery.
Q5: What should I do if I miss a dose?
Take the capsule as soon as you remember, but skip the missed dose if your next scheduled dose is drawing near.





Reviews
There are no reviews yet.